Literature DB >> 19616970

Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes.

Paul F Laeseke1, Fred T Lee, Lisa A Sampson, Daniel W van der Weide, Christopher L Brace.   

Abstract

PURPOSE: To determine whether microwave ablation with high-power triaxial antennas creates significantly larger ablation zones than radiofrequency (RF) ablation with similarly sized internally cooled electrodes.
MATERIALS AND METHODS: Twenty-eight 12-minute ablations were performed in an in vivo porcine kidney model. RF ablations were performed with a 200-W pulsed generator and either a single 17-gauge cooled electrode (n = 9) or three switched electrodes spaced 1.5 cm apart (n = 7). Microwave ablations were performed with one (n = 7), two (n = 3), or three (n = 2) 17-gauge triaxial antennas to deliver 90 W continuous power per antenna. Multiple antennas were powered simultaneously. Temperatures 1 cm from the applicator were measured during two RF and microwave ablations each. Animals were euthanized after ablation and ablation zone diameter, cross-sectional area, and circularity were measured. Comparisons between groups were performed with use of a mixed-effects model with P values less than .05 indicating statistical significance.
RESULTS: No adverse events occurred during the procedures. Three-electrode RF (mean area, 14.7 cm(2)) and single-antenna microwave (mean area, 10.9 cm(2)) ablation zones were significantly larger than single-electrode RF zones (mean area, 5.6 cm(2); P = .001 and P = .0355, respectively). No significant differences were detected between single-antenna microwave and multiple-electrode RF. Ablation zone circularity was similar across groups (P > .05). Tissue temperatures were higher during microwave ablation (maximum temperature of 123 degrees C vs 100 degrees C for RF).
CONCLUSIONS: Microwave ablation with high-power triaxial antennas created larger ablation zones in normal porcine kidneys than RF ablation with similarly sized applicators.

Entities:  

Mesh:

Year:  2009        PMID: 19616970      PMCID: PMC3309457          DOI: 10.1016/j.jvir.2009.05.029

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  22 in total

1.  Radiofrequency versus microwave ablation in a hepatic porcine model.

Authors:  Andrew S Wright; Lisa A Sampson; Thomas F Warner; David M Mahvi; Fred T Lee
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

2.  Microwave ablation with a single small-gauge triaxial antenna: in vivo porcine liver model.

Authors:  Christopher L Brace; Paul F Laeseke; Lisa A Sampson; Tina M Frey; Daniel W van der Weide; Fred T Lee
Journal:  Radiology       Date:  2007-02       Impact factor: 11.105

3.  Guidelines for power and time variables for microwave ablation in an in vivo porcine kidney.

Authors:  William W Hope; Thomas M Schmelzer; William L Newcomb; Jessica J Heath; Amy E Lincourt; H James Norton; B Todd Heniford; David A Iannitti
Journal:  J Surg Res       Date:  2008-04-28       Impact factor: 2.192

Review 4.  Reference values for resting blood flow to organs of man.

Authors:  L R Williams; R W Leggett
Journal:  Clin Phys Physiol Meas       Date:  1989-08

5.  Rising incidence of renal cell cancer in the United States.

Authors:  W H Chow; S S Devesa; J L Warren; J F Fraumeni
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

6.  Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.

Authors:  Debra A Gervais; Francis J McGovern; Ronald S Arellano; W Scott McDougal; Peter R Mueller
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

7.  Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors.

Authors:  Debra A Gervais; Ronald S Arellano; Francis J McGovern; W Scott McDougal; Peter R Mueller
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

8.  Radio frequency ablation of small renal tumors:: intermediate results.

Authors:  J J Hwang; M M Walther; S E Pautler; J A Coleman; J Hvizda; James Peterson; W M Linehan; B J Wood
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

9.  Microwave Ablation With a Triaxial Antenna: Results in ex vivo Bovine Liver.

Authors:  Christopher L Brace; Paul F Laeseke; Daniel W van der Weide; Fred T Lee
Journal:  IEEE Trans Microw Theory Tech       Date:  2005-01       Impact factor: 3.599

10.  Contribution of direct heating, thermal conduction and perfusion during radiofrequency and microwave ablation.

Authors:  W Schramm; D Yang; D Haemmerich
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2006
View more
  30 in total

1.  Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue.

Authors:  A Andreano; Yu Huang; M Franca Meloni; Fred T Lee; Christopher Brace
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

2.  Retroperitoneoscopic microwave ablation of renal hamartoma: middle-term results.

Authors:  Wei Guan; Jian Bai; Zhiquan Hu; Yaowu Su; Qianyuan Zhuang; Zhangqun Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

3.  In vitro artefact assessment of a new MR-compatible microwave antenna and a standard MR-compatible radiofrequency ablation electrode for tumour ablation.

Authors:  Rüdiger Hoffmann; Hansjörg Rempp; Frank Eibofner; David-Emanuel Keßler; Gunnar Blumenstock; Jakob Weiß; Philippe L Pereira; Konstantin Nikolaou; Stephan Clasen
Journal:  Eur Radiol       Date:  2015-07-02       Impact factor: 5.315

4.  Visualizing ex vivo radiofrequency and microwave ablation zones using electrode vibration elastography.

Authors:  Ryan J Dewall; Tomy Varghese; Chris L Brace
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

5.  Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.

Authors:  Marki E Klapperich; E Jason Abel; Timothy J Ziemlewicz; Sara Best; Meghan G Lubner; Stephen Y Nakada; J Louis Hinshaw; Christopher L Brace; Fred T Lee; Shane A Wells
Journal:  Radiology       Date:  2017-01-11       Impact factor: 11.105

6.  [Microwave tumor ablation. New devices, new applications?].

Authors:  R Hoffmann; H Rempp; S Clasen
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

7.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.

Authors:  Muneeb Ahmed; Luigi Solbiati; Christopher L Brace; David J Breen; Matthew R Callstrom; J William Charboneau; Min-Hua Chen; Byung Ihn Choi; Thierry de Baère; Gerald D Dodd; Damian E Dupuy; Debra A Gervais; David Gianfelice; Alice R Gillams; Fred T Lee; Edward Leen; Riccardo Lencioni; Peter J Littrup; Tito Livraghi; David S Lu; John P McGahan; Maria Franca Meloni; Boris Nikolic; Philippe L Pereira; Ping Liang; Hyunchul Rhim; Steven C Rose; Riad Salem; Constantinos T Sofocleous; Stephen B Solomon; Michael C Soulen; Masatoshi Tanaka; Thomas J Vogl; Bradford J Wood; S Nahum Goldberg
Journal:  Radiology       Date:  2014-06-13       Impact factor: 11.105

8.  Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients.

Authors:  P Balageas; F Cornelis; Y Le Bras; R Hubrecht; J C Bernhard; J M Ferrière; A Ravaud; N Grenier
Journal:  Eur Radiol       Date:  2013-02-27       Impact factor: 5.315

Review 9.  Contemporary minimally invasive treatment options for renal angiomyolipomas.

Authors:  Sri Sivalingam; Stephen Y Nakada
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

Review 10.  Ablative therapies for small renal tumours.

Authors:  Arturo Castro; Lawrence C Jenkins; Nelson Salas; Gideon Lorber; Raymond J Leveillee
Journal:  Nat Rev Urol       Date:  2013-04-23       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.